Stock listing

KNE Stock Price, News, Filings & Events — Kane Biotech Inc.

Selected listing: KNE · TSXV · CAD · CA

This page tracks Kane Biotech Inc.'s KNE:TSXV listing on TSXV in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KNE:TSXV. KNE:TSXV is the stock-level entry point for investors researching Kane Biotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kane Biotech Inc. is a public company listed under the ticker KNE on the Canadian market. The company has a market capitalization of approximately CAD 3.65 million. Kane Biotech focuses on developing innovative solutions for the prevention and treatment of biofilm-related infections.

KNE:TSXVCADCAUpdated August 21, 2026
Kane Biotech Inc. logo
Ticker
KNE:TSXV
Asset type
Stock
Market cap
$3.7M
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
TSXV
Currency
CAD

Kane Biotech Inc. KNE:TSXV stock context

This page tracks Kane Biotech Inc.'s KNE:TSXV listing on TSXV in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KNE:TSXV. KNE:TSXV is the stock-level entry point for investors researching Kane Biotech Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kane Biotech Inc. is a public company listed under the ticker KNE on the Canadian market. The company has a market capitalization of approximately CAD 3.65 million. Kane Biotech focuses on developing innovative solutions for the prevention and treatment of biofilm-related infections.

Latest news from Kane Biotech Inc.

All Kane Biotech Inc. news →

Research Kane Biotech Inc.

Alternate listings